Skip to main content
Livermore
Livermore
ZHEN

Samlyn Capital, LLC

SEC CIK
0001421097
Latest filing
Aug 14, 2026

The latest 13F from Samlyn Capital, LLC covers Q2 2026 (filed Aug 14, 2026): 77 long positions worth $6.03B. The top 10 holdings make up 42.2% of the portfolio, and the largest is LPL Financial Holdings Inc. (LPLA) at 11.2%. Livermore has 22 filings on Form 13F from this institution, going back to Q1 2021.

What changed in Q2 2026

Share counts compared with Q1 2026: how many positions were new, added to, reduced or sold out, and the biggest buys and sells. Dollar amounts are estimated at the quarter-end prices implied by the filing.

Full comparison
New
24
Est. +$1.01B
Added
21
Est. +$642.6M
Reduced
32
Est. −$1.48B
Sold out
22
Est. −$850.1M

Top 5 holdings

Share of this quarter's portfolio value

  1. LPLALPL Financial Holdings Inc.
    11.2%$677.6MHistory
  2. PRMBPrimo Brands Corp
    6.7%$404.1MHistory
  3. FSLRFirst Solar, Inc.
    4.1%$246.7MHistory
  4. TSMTaiwan Semiconductor Manufacturing Co Ltd
    3.5%$210.5MHistory
  5. BLKBlackRock, Inc.
    3.3%$201.2MHistory

Biggest buys

New and added positions, by estimated amount bought

  1. BWABorgwarner Inc
    +$127.3MNewHistory
  2. FSLRFirst Solar, Inc.
    +$126.1MAddedHistory
  3. BACBank of America Corp
    +$115.4MAddedHistory
  4. ITUBItau Unibanco Holding S.A.
    +$79.4MNewHistory
  5. AMATApplied Materials Inc
    +$65.6MNewHistory

Largest weight increases

New and added positions, by percentage points of the portfolio gained

  1. FSLRFirst Solar, Inc.
    +2.36 pp1.7% → 4.1%History
  2. BWABorgwarner Inc
    +2.11 pp0.0% → 2.1%History
  3. BACBank of America Corp
    +1.96 pp0.4% → 2.4%History
  4. ITUBItau Unibanco Holding S.A.
    +1.32 pp0.0% → 1.3%History
  5. AMATApplied Materials Inc
    +1.09 pp0.0% → 1.1%History

Biggest sells

Reduced and sold-out positions, by estimated amount sold

  1. JPMJPMorgan Chase & Co
    −$272.4MReducedHistory
  2. MSMorgan Stanley
    −$125.5MReducedHistory
  3. COFCapital One Financial Corp
    −$118.5MReducedHistory
  4. NVDANVIDIA Corp
    −$113.0MSold outHistory
  5. AMZNAmazon Com Inc
    −$110.2MReducedHistory

Largest weight decreases

Reduced and sold-out positions, by percentage points of the portfolio lost

  1. JPMJPMorgan Chase & Co
    −4.01 pp6.8% → 2.8%History
  2. NVDANVIDIA Corp
    −1.94 pp1.9% → 0.0%History
  3. LYVLive Nation Entertainment, Inc.
    −1.87 pp1.9% → 0.0%History
  4. COFCapital One Financial Corp
    −1.73 pp3.8% → 2.0%History
  5. MSFTMicrosoft Corp
    −1.61 pp1.6% → 0.0%History

Metrics

13F metrics for Q2 2026, computed only from the numbers in the filings. Definitions below.

Portfolio value
$6.03B
+$209.5M (+3.6%) vs. prior quarter
Positions
77
+2 vs. prior quarter
Top 10 concentration
42.2%
Top 10 as share of value
Turnover
27.9%
Q2 2026, one quarter
Average holding period
6.7 quarters
Weighted by value

How these are calculated

  • Portfolio value: the market value of all long positions in the 13F, as reported at quarter end, excluding options.
  • Top 10 concentration: the combined value of the 10 largest positions as a share of portfolio value.
  • Turnover: the smaller of this quarter's estimated purchases and estimated sales, divided by the average of this and last quarter's portfolio value. Estimates multiply the change in shares by the quarter-end price implied by the filing (market value divided by shares); new positions use this quarter's value and sold-out positions last quarter's. Only positions reported in shares count, and it is not calculated when the previous quarter was not filed.
  • Average holding period: how many consecutive quarters each current position has been held (including this one; a quarter without the position or without a filing starts the count over), weighted by this quarter's value. Counting starts with the first 13F in Livermore (Q1 2021), so positions held before then are understated.

13F filings by quarter

22 quarters, going back to Q1 2021. Bars show each quarter's 13F portfolio value; quarters without a filing are left blank.

Peak $7.04B (Q3 2025)

Q1 2021: $6.73BQ2 2021: $6.55BQ3 2021: $6.83BQ4 2021: $6.53BQ1 2022: $6.61BQ2 2022: $4.99BQ3 2022: $5.24BQ4 2022: $5.10BQ1 2023: $5.44BQ2 2023: $5.76BQ3 2023: $5.65BQ4 2023: $4.60BQ1 2024: $5.75BQ2 2024: $5.82BQ3 2024: $6.19BQ4 2024: $6.29BQ1 2025: $6.07BQ2 2025: $6.89BQ3 2025: $7.04BQ4 2025: $6.27BQ1 2026: $5.82BQ2 2026: $6.03B
Q1 2021Q2 2026
13F filings of Samlyn Capital, LLC by quarter
QuarterFiledPositionsValueTop 3 holdingsChangesFiling
Q2 2026Aug 14, 202677$6.03BLPLAPRMBFSLRvs. Q1 2026SEC
Q1 2026May 15, 202675$5.82BLPLAJPMPRMBvs. Q4 2025SEC
Q4 2025Feb 17, 202673$6.27BLPLABACCOFvs. Q3 2025SEC
Q3 2025Nov 14, 202573$7.04BFSLRLPLACOFvs. Q2 2025SEC
Q2 2025Aug 14, 202569$6.89BCOFLPLABACvs. Q1 2025SEC
Q1 2025May 15, 202577$6.07BLPLABACCOFvs. Q4 2024SEC
Q4 2024Feb 14, 202587$6.29BLPLABACFSLRvs. Q3 2024SEC
Q3 2024Nov 14, 202484$6.19BLPLAMSFTPFEvs. Q2 2024SEC
Q2 2024Aug 14, 202486$5.82BLPLAFSLRMSFTvs. Q1 2024SEC
Q1 2024May 15, 202488$5.75BFSLRLPLAMETAvs. Q4 2023SEC
Q4 2023Feb 14, 202471$4.60BFSLRLPLANTRAvs. Q3 2023SEC
Q3 2023Nov 14, 202394$5.65BLPLAVanguard Morningstar Large-Cap ETFFSLRvs. Q2 2023SEC
Q2 2023Aug 14, 202384$5.76BVanguard Morningstar Large-Cap ETFLPLAVOYAvs. Q1 2023SEC
Q1 2023May 15, 202388$5.44BVanguard Morningstar Large-Cap ETFLPLAVOYAvs. Q4 2022SEC
Q4 2022Feb 14, 202389$5.10BVanguard Morningstar Large-Cap ETFLPLAVOYAvs. Q3 2022SEC
Q3 2022Nov 14, 202288$5.24BLPLAVanguard Morningstar Large-Cap ETFVOYAvs. Q2 2022SEC
Q2 2022Aug 15, 202285$4.99BLPLAVanguard Morningstar Large-Cap ETFVOYAvs. Q1 2022SEC
Q1 2022May 16, 2022105$6.61BVanguard Morningstar Large-Cap ETFLPLAVOYAvs. Q4 2021SEC
Q4 2021Feb 14, 2022107$6.53BVanguard Morningstar Large-Cap ETFLPLAVOYAvs. Q3 2021SEC
Q3 2021Nov 15, 2021137$6.83BLPLAPAGSVanguard Morningstar Large-Cap ETFvs. Q2 2021SEC
Q2 2021Aug 16, 2021159$6.55BLPLAPAGSDISvs. Q1 2021SEC
Q1 2021May 17, 2021143$6.73BLPLATGTAthene Holding Ltd.–SEC

13D and 13G filings

Companies where Samlyn Capital, LLC reports owning 5% or more on Schedule 13D or 13G, and its latest filings.

Current stakes of 5% or more

1 company, largest stake first.

Companies where Samlyn Capital, LLC owns 5% or more
CompanyLatest formStakeChangeFirst filedLatest filingFiling
VINPVinci Compass Investments Ltd.13G6.00%3.04M shares+1.20 ppfrom 4.80%Feb 14, 20235 filingsAug 14, 2026SEC

Latest filings

44 filings on file made by Samlyn Capital, LLC or listing it as a reporting person; the latest 20 are shown.

Schedule 13D and 13G filings by Samlyn Capital, LLC
CompanyFiled (ET)FormStakeChangeEvent dateFiling
VINPVinci Compass Investments Ltd.Aug 14, 20261:35 PM ET13G6.00%3.04M shares+1.20 ppfrom 4.80%Jun 30, 2026SEC
PCTPureCycle Technologies, Inc.May 15, 20261:39 PM ET13G/A4.20%7.90M shares−3.00 ppfrom 7.20%Below 5%Mar 31, 2026SEC
PCTPureCycle Technologies, Inc.Nov 14, 20251:33 PM ET13G/A7.20%13.6M shares−1.60 ppfrom 8.80%Sep 30, 2025SEC
PCTPureCycle Technologies, Inc.Aug 14, 20251:38 PM ET13G/A8.80%16.7M shares+2.30 ppfrom 6.50%Jun 30, 2025SEC
CRVSCorvus Pharmaceuticals, Inc.Aug 14, 20251:32 PM ET13G/A0.00%0 shares−6.00 ppfrom 6.00%Below 5%Jun 30, 2025SEC
VINPVinci Compass Investments Ltd.May 15, 20253:36 PM ET13G/A4.80%2.36M shares−1.40 ppfrom 6.20%Below 5%Mar 31, 2025SEC
NKTRNektar TherapeuticsMay 15, 20253:35 PM ET13G/A0.00%0 shares−5.20 ppfrom 5.20%Below 5%Mar 31, 2025SEC
CRVSCorvus Pharmaceuticals, Inc.May 15, 20253:34 PM ET13G/A6.00%4.07M shares−3.80 ppfrom 9.80%Mar 31, 2025SEC
VINPVinci Compass Investments Ltd.Feb 14, 20252:01 PM ET13G/A6.20%2.36M shares–Dec 31, 2024SEC
INZYInozyme Pharma, Inc.Feb 14, 20251:59 PM ET13G/A0.00%0 shares–Below 5%Dec 31, 2024SEC
PCTPureCycle Technologies, Inc.Feb 14, 20251:57 PM ET13G/A6.50%11.7M shares–Dec 31, 2024SEC
CRVSCorvus Pharmaceuticals, Inc.Feb 14, 20251:53 PM ET13G/A9.80%6.67M shares–Dec 31, 2024SEC
NKTRNektar TherapeuticsFeb 14, 20251:49 PM ET13G5.20%9.67M sharesNewDec 31, 2024SEC
MRUSMerus N.V.Nov 14, 202413G/AOld format–––SEC
AMNLApplied Minerals, Inc.Nov 1, 202413D/AOld format–––SEC
PCTPureCycle Technologies, Inc.Sep 20, 202413G/AOld format–––SEC
CRVSCorvus Pharmaceuticals, Inc.Aug 1, 202413G/AOld format–––SEC
CRVSCorvus Pharmaceuticals, Inc.May 13, 202413G/AOld format–––SEC
AMNLApplied Minerals, Inc.Mar 11, 202413D/AOld format–––SEC
VINPVinci Compass Investments Ltd.Feb 14, 202413G/AOld format–––SEC